Tarpon Biosystems was formed to uniquely address critical needs in the biopharmaceutical industry to reduce production costs and add the much-needed flexibility in purification operations. Tarpon has identified and combined unique technologies to provide proprietary, disposable-based technology, which enables the use of highly efficient, low cost industrial purification processes widely employed in other industries. Our technology, called BioSMB^™, adapts a proven manufacturing technology for use in the biomanufacturing environment. BioSMB^TM systems incorporate disposable components to enable flexible, multi-product biomanufacturing, all at a significantly reduced cost.

Events

Upcoming Events

       Updating soon

Past Events

• November 1-3, 2010: BMD Summit, Boston, MA; Panel Discussion "Facility Rationalization: Resolving Facility-Driven, Rather than Capacity-Driven, Bottlenecks"


• September 21-24, 2010: Bioprocess International, Providence, RI - Sponsor of Roundtable Discussion "Continuous Disposable Multi-Column Chromatography: Emerging Technology To Enable More Efficient Downstream Processing"


• August 1-6, 2010: Recovery XIV Conference; Scientific talk submitted using BioSMB by Biogen-IDEC


• June 14-16, 2010: IBC Single Use Bioprocess Systems and Applications; co-sponsored panel discussion with Xcellerex and presentation by Hua Jiang of Novavax presenting BioSMB data on vaccine purification.

Publications

• BioProcess International December 2010 Supplement, Single-Use Systems As Principal Components in Bioproduction


• BioProcess International June 2009 Supplement. "Single-Use, Continuous-Countercurrent, Multicolumn Chromatography"


• An Open Platform for Biopharmaceutical Purification